Clinical Trial for Advanced Bile Duct Cancer

0 Views
administrator
administrator
07/01/23

Learn about a phase II multi-center study evaluating combination immunotherapy for advanced cholangiocarcinoma (bile duct cancer) with pembrolizumab and Sylatron (peginterferon alfa-2b): HCRN GI16-263. https://hoosiercancer.org/clin....ical-trials/trial/gi

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next